217 related articles for article (PubMed ID: 31166103)
1. Can preoperative multiparametric MRI avoid unnecessary prostate biopsies before holmium laser enucleation of the prostate? Preliminary results of a multicentric cohort of patients.
Giampaoli M; Bianchi L; D'agostino D; Corsi P; Romagnoli D; Mineo Bianchi F; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Porreca A
Minerva Urol Nefrol; 2019 Oct; 71(5):524-530. PubMed ID: 31166103
[TBL] [Abstract][Full Text] [Related]
2. "In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation.
Porreca A; D'Agostino D; Vigo M; Corsi P; Romagnoli D; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Giampaoli M
Arch Ital Urol Androl; 2020 Jan; 91(4):224-229. PubMed ID: 31937084
[TBL] [Abstract][Full Text] [Related]
3. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
Herlemann A; Wegner K; Roosen A; Buchner A; Weinhold P; Bachmann A; Stief CG; Gratzke C; Magistro G
World J Urol; 2017 Nov; 35(11):1777-1782. PubMed ID: 28516315
[TBL] [Abstract][Full Text] [Related]
4. HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysis.
Rosenhammer B; Lausenmeyer EM; Mayr R; Burger M; Eichelberg C
World J Urol; 2018 Dec; 36(12):2035-2041. PubMed ID: 29858700
[TBL] [Abstract][Full Text] [Related]
5. Preoperative multiparametric prostate magnetic resonance imaging: a safe clinical practice to reduce incidental prostate cancer in Holmium laser enucleation of the prostate.
Porreca A; Giampaoli M; Bianchi L; D'Agostino D; Romagnoli D; Bianchi FM; Rosso AD; Corsi P; Schiavina R; Artibani W; Brunocilla E
Cent European J Urol; 2019; 72(2):106-112. PubMed ID: 31482016
[TBL] [Abstract][Full Text] [Related]
6. Holmium Laser Enucleation of Prostate Within 6 Weeks of Transrectal Ultrasound Guided Prostate Biopsy is Safe and Effective.
Etafy MH; Katz JE; Gonzalgo MR; Garcia Lopez EA; Shah RH; Banerjee I; Smith N; Shah HN
Urology; 2021 Feb; 148():88-92. PubMed ID: 33227302
[TBL] [Abstract][Full Text] [Related]
7. Incidental Prostate Cancer Diagnosis Is Common After Holmium Laser Enucleation of the Prostate.
Sakai A; Borza T; Antar A; Richmond E; Allen GO; Knoedler M; Manakas C; Huang W; Gralnek D; Grimes MD
Urology; 2024 Jan; 183():170-175. PubMed ID: 38043905
[TBL] [Abstract][Full Text] [Related]
8. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
[TBL] [Abstract][Full Text] [Related]
9. Incidental prostate cancer after holmium laser enucleation of the prostate: incidence and predictive factors for clinical progression.
Klein C; Marquette T; Capon G; Yacoub M; Alezra E; Bernhard JC; Bladou F; Robert G
Int J Clin Oncol; 2022 Jun; 27(6):1077-1083. PubMed ID: 35333999
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Multiparametric Magnetic Resonance Imaging on Treatment Strategies for Incidental Prostate Cancer after Holmium Laser Enucleation of the Prostate.
Ko KJ; Choi S; Song W
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510942
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of High-Powered Holmium Laser Enucleation of the Prostate within 1-3 Weeks Following Prostate Biopsy.
Yıldız A; Akdemir S; Anıl H; Arslan M
Urol Int; 2021; 105(9-10):852-857. PubMed ID: 33780959
[TBL] [Abstract][Full Text] [Related]
12. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
Pessoa RR; Viana PC; Mattedi RL; Guglielmetti GB; Cordeiro MD; Coelho RF; Nahas WC; Srougi M
BJU Int; 2017 Apr; 119(4):535-542. PubMed ID: 27500389
[TBL] [Abstract][Full Text] [Related]
13. Transrectal ultrasound examination of prostate cancer guided by fusion imaging of multiparametric MRI and TRUS: avoiding unnecessary mpMRI-guided targeted biopsy.
Xu G; Li JH; Xiang LH; Yang B; Chen YC; Sun YK; Zhao BH; Wu J; Sun LP; Xu HX
Asian J Androl; 2023; 25(3):410-415. PubMed ID: 36348578
[TBL] [Abstract][Full Text] [Related]
14. Incidental prostate cancer at holmium laser enucleation of prostate.
Shvero A; Teplitsky S; Klonicke E; Das AK
Can J Urol; 2021 Dec; 28(6):10900-10906. PubMed ID: 34895394
[TBL] [Abstract][Full Text] [Related]
15. Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer.
Panebianco V; Valerio MC; Giuliani A; Pecoraro M; Ceravolo I; Barchetti G; Catalano C; Padhani AR
Eur Urol Oncol; 2018 Aug; 1(3):208-214. PubMed ID: 31102623
[TBL] [Abstract][Full Text] [Related]
16. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
[TBL] [Abstract][Full Text] [Related]
17. Comparison of classical transrectal prostate biopsy versus cognitive registration in rebiopsy.
Barbas Bernardos G; Herranz Amo F; de Miguel Campos E; Luis Cardo A; Herranz Arriero A; Cancho Gil MJ; Caño Velasco J; Jara Rascón J; Mayor de Castro J; Hernández Fernández C
Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):228-233. PubMed ID: 30833102
[TBL] [Abstract][Full Text] [Related]
18. A non-randomized prospective study on the diagnostic performance of perineal prostatic biopsy, directed via diffusion nuclear resonance, in patients with suspected prostate cancer and previous negative transrectal prostate biopsy.
Castellucci R; Linares Quevedo AI; Sánchez Gómez FJ; Cogollos Acuña I; Salmerón Béliz I; Muñoz Fernández de Legaría M; Salinas S; Martínez Piñeiro L
Urologia; 2021 Feb; 88(1):69-76. PubMed ID: 33054607
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.
Choi YH; Kang MY; Sung HH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Kim CK; Park BK; Lee HM
Clin Genitourin Cancer; 2019 Feb; 17(1):e19-e25. PubMed ID: 30415878
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams).
Tan AH; Gilling PJ; Kennett KM; Frampton C; Westenberg AM; Fraundorfer MR
J Urol; 2003 Oct; 170(4 Pt 1):1270-4. PubMed ID: 14501739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
